OTC - ACTIVE INGREDIENT SECTION
allantoin
allantoin
water, propylene glycol, cetearyl alcohol, niacinamide, sodium hyaluronate, sorbitan stearate, dimethicon, etc
anti-wrinkle
skin protectant
keep out or reach of the children
apply a moderate amount evenly after soothng mist has been fully absorbed
-If in contact with the eyes, wash out thoroughty with water If the symptoms are servere, seek medical advice immediately
-This product is for exeternal use only. Do not use for internal use
-If possible, avoid direct sunlight and store in cool and area of low humidity
-In order to maintain the quality of the product and avoid misuse
-Avoid placing the product near fire and store out in reach of children
for external use only
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 69327-8001-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-bd07-f424-e053-dadaa90a57ce | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69327-8001-1 | M-Rose Seaweed Essence Serum | 50 mL in 1 BOTTLE | CREAM | 50 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 69327-8001 | M-ROSE SEAWEED ESSENCE SERUM (ALLANTOIN) CREAM [BEAUTY LINE CO., LTD.] | 1 | Legacy NDC, 1 package rows | 20141026_bb88f118-8097-4b36-8ef8-11dd279f18c2.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ALLANTOIN | ACTIVE INGREDIENT | 344S277G0Z | 1 | |
| ALLANTOIN | ACTIVE MOIETY | 344S277G0Z | 1 | |
| HYALURONATE SODIUM | INACTIVE INGREDIENT | YSE9PPT4TH | 1 | |
| NIACINAMIDE | INACTIVE INGREDIENT | 25X51I8RD4 | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 69327-8001 | 69327-8001-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ALLANTOIN | 344S277G0Z | ACTIB |
| WATER | 059QF0KO0R | IACT |
| NIACINAMIDE | 25X51I8RD4 | IACT |
| HYALURONATE SODIUM | YSE9PPT4TH | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRA-ARTICULAR | 23 mg | ||
| NIACINAMIDE | NIACINAMIDE | 25X51I8RD4 | CREAM / TOPICAL | NA | ||
| NIACINAMIDE | NIACINAMIDE | 25X51I8RD4 | GEL / TOPICAL | 25 mg | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRAVITREAL | 23 mg | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | GEL / TOPICAL | 463 mg | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | LOTION / TOPICAL | 0.01 %w/w | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRAMUSCULAR | 23 mg | ||
| NIACINAMIDE | NIACINAMIDE | 25X51I8RD4 | INJECTION / INTRAVENOUS | 2.5 %w/v | ||
| NIACINAMIDE | NIACINAMIDE | 25X51I8RD4 | INJECTION / INTRAMUSCULAR | 2.5 %w/v |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| e789c3dd-0256-41bf-a0c1-fda808b152af | bb88f118-8097-4b36-8ef8-11dd279f18c2 | 2014-10-25 | Warnings | e789c3dd-0256-41bf-a0c1-fda808b152af bb88f118-8097-4b36-8ef8-11dd279f18c2 |
Adverse event summaries are temporarily unavailable. Other product information remains available.